Safety and neutralization antibody levels of inactivated SARS-CoV-2 vaccine in adult patients with Myasthenia Gravis: a prospective observational cohort study
DiscussionThe safety of the SARS-CoV-2 inactivated vaccine was reconfirmed in this study. No significant difference in Nabs level was found between patients with MG and HCs. Nabs levels correlated with AChR-Ab levels before vaccination and ΔAChR-Ab levels.
Source: Neurological Sciences - Category: Neurology Source Type: research
More News: Autoimmune Disease | Brain | Myasthenia Gravis | Neurology | SARS | Statistics | Study | Vaccines